Background Monopharmacy with antipsychotics and antidepressants is the first-line
treatment for schizophrenia and major depressive disorder (MDD) in most clinical …

Importance Patients with late-life schizophrenia (LLS) are highly susceptible to antipsychotic
adverse effects. Treatment guidelines endorse lower antipsychotic doses. However, the …

Although switching to antipsychotic monotherapy improves patient outcomes in
schizophrenia, antipsychotic deprescribing is rarely performed, and its use varies between …

Although patients with schizophrenia are reported to have excess mortality compared with
the general population, many affected patients will nonetheless survive and continue to …

Background: There is a lack of national level data from India on prescription of psychotropics
by psychiatrists. Aim and Objective: This study aimed to assess the first prescription handed …

Aim: There is lack of data on prescription patterns in elderly patients from developing
countries. The aim of this study is to examine the first prescription given to elderly patients …

While indicated for schizophrenia and acute mania, ziprasidone's evidence base and use in
clinical practice extends beyond these regulatory approvals. We, an invited panel of experts …

Objective To identify descriptors of Antipsychotic (AP) prescription, focusing on second
generation antipsychotics (SGAs), polypharmacy, and long-acting injections (LAIs). Methods …

Prescribing antipsychotics in geriatric patients: Focus on schizophrenia and bipolar disorder |
MDedge Psychiatry Skip to main content Home Psychiatry ALL Specialities ALL Specialities …

Minimally effective doses of antipsychotics are likely influenced by several clinical and
demographic characteristics of patients, with age being one of the most important elements …